American Healthcare REIT AHR
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
American Healthcare REIT (AHR) Business Model and Operations Summary
American Healthcare REIT Inc is a healthcare-focused real estate investment trust. It owns a diversified portfolio of clinical healthcare real estate properties, focusing on medical office buildings, skilled nursing facilities, senior housing, hospitals, and other healthcare-related facilities. It has four reportable business segments: integrated senior health campuses, outpatient medical, triple-net leased properties and SHOP. It generates majority of its revenue through Integrated Senior Health Campuses segment.
Key Insights
American Healthcare REIT (AHR) Core Market Data and Business Metrics
Latest Closing Price
$30.78Market Cap
$4.81 BillionPrice-Earnings Ratio
-106.14Total Outstanding Shares
157.57 Million SharesTotal Employees
114Dividend
$0.25 Per Share QuarterlyIPO Date
February 7, 2024SIC Description
Real Estate Investment TrustsPrimary Exchange
New York Stock ExchangeHeadquarters
18191 Von Karman Avenue, Irvine, CA, 92612
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Financing Activities, Continuing | $-134.74 Million |
| Exchange Gains/Losses | $-91,000 |
| Net Cash Flow From Financing Activities | $-134.74 Million |
| Net Cash Flow From Investing Activities | $-8.73 Million |
| Net Cash Flow From Operating Activities, Continuing | $176.09 Million |
| Net Cash Flow | $32.52 Million |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Operating Expenses | $-133.63 Million |
| Net Income/Loss Available To Common Stockholders, Basic | $-37.81 Million |
| Cost Of Revenue | $1.65 Billion |
| Preferred Stock Dividends And Other Adjustments | $0 |
| Income/Loss From Continuing Operations After Tax | $-35.60 Million |
| Net Income/Loss Attributable To Redeemable Noncontrolling Interest | $-351,000 |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss Attributable To Parent | $-37.90 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $2.21 Million |
| Other Comprehensive Income/Loss | $-87,000 |
| Comprehensive Income/Loss | $-35.69 Million |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Temporary Equity | $220,000 |
| Liabilities | $2.18 Billion |
| Liabilities And Equity | $4.49 Billion |
| Intangible Assets | $161.47 Million |
| Redeemable Noncontrolling Interest | $220,000 |
| Inventory | $19.48 Million |
Historical Dividends
Current dividend: $0.25 Per Share Quarterly
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| Mar 19, 2025 | Apr 17, 2025 | Mar 31, 2025 | $0.25 | Quarterly |
| Dec 18, 2024 | Jan 17, 2025 | Dec 31, 2024 | $0.25 | Quarterly |
| Sep 6, 2024 | Oct 18, 2024 | Sep 20, 2024 | $0.25 | Quarterly |
| Jun 12, 2024 | Jul 19, 2024 | Jun 27, 2024 | $0.25 | Quarterly |
| Mar 15, 2024 | Apr 19, 2024 | Mar 28, 2024 | $0.25 | Quarterly |